Partnerships and Investors

Prevtec Microbia has a strong network of partners that enabled it to finalize the development and commercialization of its Coliprotec® vaccine line. These long-term relationships provide the company with a competitive advantage for its future development.

Elanco Animal Health is the exclusive distributor of Coliprotec® vaccines in Canada and the European Union. Elanco is a global innovation-driven company that develops and markets products that improve the health of animals and livestock productivity in nearly 70 countries.
It is one of the largest animal health companies in the world. Elanco is a division of Eli Lilly and Company, a leading Fortune 500 pharmaceutical company.

Université de Montréal’s Faculty of Veterinary Medicine is located in Saint-Hyacinthe, in the heart of Quebec’s largest agri-food region. It is the only veterinary medicine teaching and research unit in Quebec and the only French-language faculty of veterinary medicine in North America. It has multiple research units devoted to issues related to food animals and pets.

Telesystem is a family-owned media and technology holding. The company’s long-term value is driven by innovation, strategic partnerships, international scalability, mergers and acquisitions.

CZ Veterinaria (CZV), based in Spain, manufactures Coliprotec® vaccines for distribution in European Union countries. CZV is dedicated exclusively to the development and manufacturing of veterinary medicines and vaccines.

Investissement Québec’s mission is to assist companies and contribute to Québec’s economic development. During its last fiscal year, Investissement Québec participated in more than 80 funds supporting the development of innovative projects.

Klifovet, based in Munich, Germany, is a full-service contract research and development organization offering management of project development, regulatory affairs, GMP-compliant clinical supply services, quality assurance, data management and statistical analysis for the animal health and nutrition industry.

Diamond Animal Health manufactures Coliprotec® vaccines in North America. It is a subsidiary of Heska Corporation, which is based in Colorado, in the United States. Diamond Animal Health is a leading manufacturer of USDA-approved biological products and FDA-approved pharmaceutical animal health products.

INRS, Institut national de recherche scientifique (Institut Armand-Frappier), is a graduate and post-graduate school consisting of four research centres in various cities in Quebec. INRS plays a key role in the advancement of knowledge and the training of highly qualified young scientists in strategic research areas, both in Quebec and elsewhere in the world.

Capital régional et coopératif Desjardins is a development capital investment fund that takes an active role in the development of small and medium-sized Quebec enterprises.

Lynden International Logistics Co. is a third-party logistics company with over 60 years of qualified experience in the warehousing and distribution sector. Lynden International Logistics Co. offers a wide range of third-party warehousing and logistics services to the animal health industry with GMP and Drug Establishment licensed facilities strategically located across Canada.

Klifovet, based in Munich, Germany, is a full-service contract research and development organization offering management of project development, regulatory affairs, GMP-compliant clinical supply services, quality assurance, data management and statistical analysis for the animal health and nutrition industry.

Accès Capital Québec is a venture capital company whose mission is to invest in small and medium-size enterprises with strong growth potential.

JEFO specializes in the design, manufacture, warehousing and just-in-time distribution of animal feed products. It has its head office in Quebec and offices on five continents.

Jafaco Gestion is an investment company belonging to Groupe Délimax, a vertically integrated calf and sheep production company. Délimax is the largest calf production company in North America.

Écho Capital FIER Outaouais is a fund that invests in small and medium-sized private Quebec companies, especially high-technology companies.

Trifermed is a contract business development organization with offices in Europe and North America. It provides support to the pharmaceutical, biotechnology and medical device industries in the form of business development services.

Grupo Fuertes, a holding company based in Spain, invests in private companies that operate in the leisure, telecommunications, transport, R&D and biotechnology industries.

Gestion Univalor is a limited partnership whose mission is to commercialize the outcomes of research conducted at Université de Montréal, Polytechnique Montréal and HEC Montréal.

Distribution network

Coliprotec® vaccines are currently available for sale in many countries. In some geographic areas, they have been approved for sale and are now at the commercialization stage.

Coliprotec® vaccines are currently available for sale in Canada and in several countries in the European Union. In some geographic areas, they have been approved for sale and are now at the commercialization stage.

Approved
in 33 countries


Product:
Approved for sale :
Distributor:
Website:
Potential partners

Commercial
partners

Commercial
partners
Prevtec Microbia aims to commercialize innovative animal health products around the world. We are always on the lookout for new partners to help us manufacture, distribute and market our products.

Interested in becoming a commercial partner?

Technological
partners

Technological
partners
Prevtec Microbia is on the lookout for promising innovative technologies that align with our mission and meet the needs of veterinarians and food animal producers.

We have successfully developed and commercialized an innovative product in multiple regions (Canada and the European Union), from discovery through proof of concept to production scale-up and regulatory approval. Because of our size, we are agile, fast and efficient, and work closely with researchers and discoverers of new technologies looking to market their solutions.

Interested in becoming a technological partner?

Financial
partners

Financial
partners
Our business model minimizes the risks inherent in developing and marketing innovative products of scientific research. It is key to meeting our long-term growth objectives.

Interested in becoming a financial partner?